Haribabu Viswanathan, Girigoswami Koyeli, Sharmiladevi Palani, Girigoswami Agnishwar
Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital & Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai 603 103, India.
ACS Biomater Sci Eng. 2020 Aug 10;6(8):4377-4389. doi: 10.1021/acsbiomaterials.0c00409. Epub 2020 Jul 20.
Molecular imaging has gained utmost importance in the recent past in early diagnosis of diseases. In comparison to other imaging modalities, magnetic resonance imaging (MRI) has proven to extend its abilities not only for its usage of non-ionizing radiation but also for the high spatial resolution in soft tissues. A major limitation faced by MRI is the sensitivity in detecting diseased conditions until a certain stage. At present, this limitation is overcome with the use of contrast agents that show potential in altering the T1 and T2 relaxation times of the hydrogen protons. This modulation to the relaxation times leads to better contrast differences based on the type of contrast agent and the pulse sequence being engaged for acquiring images. Water molecules, as the major contributor of hydrogen protons, are proven to interact with such contrast agents. Major drawbacks noted with the marketed MRI contrast agents are their toxicity and renal clearance. To conquer these issues, magnetic nanomaterials are being researched for their abilities to match the contrast enhancement offered by traditional agents reducing their drawbacks. Furthermore, comparative diagnosis with both T1 and T2 contrast at the same time has also interested investigators. To achieve this, twin mode T1 and T2 weighted contrast agents are developed utilizing the remarkable properties extended by magnetic nanoplatforms. As a step forward, multimodal imaging agents are also being engineered based on these magnetic nanoplatforms that will generate cross-verified diagnoses using multiple imaging modalities with a unique imaging agent. This review starts by introducing the basics of MRI with major focus on the typical interactions of water molecules with a variety of magnetic nanomaterials. The review also concentrates on the clinical needs and nanomaterials available for twin T1 and T2 contrast with a minor introduction to multimodal imaging agents. In conclusion, the advent of MRI with the advantages offered by magnetic nanomaterials is summarized, leading to insights for future developments.
近年来,分子成像在疾病的早期诊断中变得极为重要。与其他成像方式相比,磁共振成像(MRI)不仅因其使用非电离辐射,还因其在软组织中的高空间分辨率,已证明扩展了其能力。MRI面临的一个主要限制是在疾病发展到一定阶段之前检测疾病状况的敏感性。目前,通过使用能够改变氢质子T1和T2弛豫时间的造影剂克服了这一限制。对弛豫时间的这种调节基于造影剂的类型和用于采集图像的脉冲序列,导致更好的对比度差异。水分子作为氢质子的主要贡献者,已被证明与这类造影剂相互作用。市售MRI造影剂的主要缺点是它们的毒性和肾清除率。为了克服这些问题,正在研究磁性纳米材料,以了解它们是否有能力匹配传统造影剂提供的对比度增强效果,同时减少其缺点。此外,同时进行T1和T2对比的比较诊断也引起了研究人员的兴趣。为了实现这一点,利用磁性纳米平台所具有的卓越性能开发了双模式T1和T2加权造影剂。更进一步,基于这些磁性纳米平台还在设计多模态成像剂,这些成像剂将使用独特的成像剂通过多种成像方式生成交叉验证的诊断结果。本综述首先介绍MRI的基础知识,主要关注水分子与各种磁性纳米材料的典型相互作用。该综述还集中讨论了双T1和T2对比的临床需求和可用的纳米材料,并对多模态成像剂进行了简要介绍。总之,总结了MRI的出现以及磁性纳米材料所提供的优势,为未来的发展提供了见解。